Andrea Morandi Selected Research

Proto-Oncogene Proteins c-ret

12/2016	Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts.
6/2013	GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.
3/2011	RET in breast cancer: functional and therapeutic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Morandi Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 01/2011
9	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2011
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2015
3	Melanoma (Melanoma, Malignant) 01/2021 - 04/2014
3	Carcinogenesis 01/2018 - 08/2017
3	Neoplasm Metastasis (Metastasis) 01/2017 - 10/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 05/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Hearing Loss (Hearing Impairment) 12/2020
1	Hypothyroidism 01/2020
1	Osteoporosis 01/2017
1	Pain (Aches) 01/2017
1	Hypoxia (Hypoxemia) 09/2015
1	Neuroblastoma 06/2014
1	Colonic Neoplasms (Colon Cancer) 09/2013
1	Leukemia 09/2013
1	Thyroid Neoplasms (Thyroid Cancer) 09/2013
1	medullary Thyroid cancer 09/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2013
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2011
1	Inflammation (Inflammations) 03/2008

Drug/Important Bio-Agent (IBA)

5	Estrogen ReceptorsIBA 10/2020 - 06/2013
4	Estrogens (Estrogen)FDA Link 10/2020 - 06/2013
4	Phosphotransferases (Kinase)IBA 01/2018 - 05/2011
3	LipidsIBA 05/2022 - 01/2018
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 10/2020 - 09/2013
3	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 02/2014
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2016
3	Proto-Oncogene Proteins c-retIBA 12/2016 - 03/2011
3	Aromatase InhibitorsIBA 12/2016 - 06/2013
2	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2018 - 01/2018
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 12/2016 - 06/2013
2	LigandsIBA 06/2013 - 03/2011
2	Macrophage Colony-Stimulating FactorIBA 01/2011 - 03/2008
1	EnzymesIBA 01/2021
1	GlutaminaseIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	human ERBB2 proteinIBA 10/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2020
1	palbociclibIBA 10/2020
1	Thyroid HormonesIBA 01/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2020
1	Waste Products (Waste Product)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Aspartic Acid (Aspartate)FDA Link 01/2019
1	NAD (NADH)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Pyruvate Dehydrogenase (Lipoamide)-Phosphatase (Pyruvate Dehydrogenase Phosphatase)IBA 01/2018
1	Zoledronic Acid (Zometa)FDA Link 01/2017
1	cabozantinibIBA 12/2016
1	Aromatase (CYP19)IBA 12/2016
1	NVP-AST487IBA 12/2016
1	NVP-BBT594IBA 12/2016
1	Sunitinib (Sutent)FDA Link 12/2016
1	Letrozole (Femara)FDA LinkGeneric 12/2016
1	Imiquimod (Aldara)FDA LinkGeneric 10/2016
1	triphenylmethaneIBA 10/2016
1	SOXB1 Transcription FactorsIBA 10/2016
1	Gentian Violet (Violet, Crystal)FDA Link 10/2016
1	Anastrozole (Arimidex)FDA LinkGeneric 03/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	Tyrosine (L-Tyrosine)FDA Link 09/2015
1	Pyruvate KinaseIBA 09/2015
1	Cysteine (L-Cysteine)FDA Link 09/2015
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 06/2014
1	calpeptinIBA 04/2014
1	ilomastatIBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	vandetanib (ZD6474)IBA 09/2013
1	ponatinibIBA 09/2013
1	CytokinesIBA 06/2013
1	Small Interfering RNA (siRNA)IBA 05/2011
1	Cyclin D1IBA 01/2011

Therapy/Procedure

14	Therapeutics 07/2022 - 01/2011
1	Precision Medicine 07/2022
1	Radiotherapy 07/2022
1	Molecular Targeted Therapy 07/2022
1	Castration 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Hearing Aids (Hearing Aid) 12/2020
1	Immunotherapy 10/2016